I bought 1100 shares of Exelixis (EXEL) at $8.78 in the Port today. They presented great data at ASCO and Mr. Market seems to have overstated the side effect dangers.
I will have more to say later on, but I wanted to post disclosure ASAP.
Regards,
Trond
skip to main |
skip to sidebar
Random thoughts about life, personal finance, society... Reading and writing central ... There are lots of things to celebrate AND to whine about. Come join the fun!
About Me
- Trond
- Aguanga, California, United States
- This is my personal blog. Opinions expressed here are personal and have nothing to do with my employer or work.
Important Websites
Labels
- 24% (4)
- 401(k) (5)
- AAB-001 (7)
- AcelRx (1)
- ACRX (1)
- AIG (1)
- Allos (9)
- Alzheimer's (4)
- Alzheimer's Disease (4)
- AMAG Pharma (6)
- American Idol (1)
- American Oriental (6)
- Antonio Brown (1)
- Arena (22)
- ARNA (3)
- ARQL (2)
- ArQule (2)
- bailout (5)
- Banks (1)
- Barack Obama (2)
- Bear market (1)
- Berkshire Hathaway (1)
- Bernanke (1)
- BioCryst (6)
- Biotime (3)
- BMW Method (1)
- Brock Osweiler (1)
- BTX (2)
- Buffett (3)
- Cam Newton (1)
- Cardiome (2)
- Celldex (2)
- Celsion (26)
- Chase (1)
- CLDA (1)
- CLDX (1)
- CLSN (15)
- contest (4)
- Corcept (1)
- CORT (1)
- Covered calls (27)
- credit cards (1)
- credit scores (1)
- David Cook (1)
- DCTH (1)
- Debit cads (1)
- Deep Capture (3)
- Delcath (7)
- Dendreon (50)
- Denninger (2)
- Discovery Labs (2)
- diversification (1)
- dividends (2)
- DNDN (5)
- DRIP (1)
- Elan (31)
- Electro-Optical (9)
- endorsement (1)
- entrepreneur (2)
- EXEL (3)
- Exelixis (2)
- fantasy football (1)
- FDA (3)
- Federal Reserve (3)
- fiction (3)
- Financial Planning (3)
- Four Money Steps (1)
- frugal (2)
- GenVec (9)
- ghosts (1)
- Great Depression (1)
- Greek Bailout (1)
- HARP (1)
- Heartstone Capital Management (2)
- hedge funds (2)
- hemp (1)
- Hillary Clinton (1)
- IMF (1)
- inflation (3)
- Inkitt (1)
- investment adviser (1)
- Investment Management (3)
- IRA (8)
- IRS (2)
- Javelin (1)
- John McCain (2)
- LBYM (1)
- Lexicon (2)
- Libertarian (1)
- LXRX (1)
- MannKind (5)
- mark-to-market (1)
- Marketocracy (3)
- MarketWatch (2)
- Medicare (1)
- Micromet (2)
- MITI (2)
- mortgages (1)
- Mothers Day (1)
- mutual funds (3)
- mystery (2)
- Nanoviricides (4)
- Nasdaq (1)
- NBIX (3)
- Neurocrine (13)
- newsletter (1)
- Nimrud (1)
- NNVC (1)
- NSCLC (1)
- Nvidia (2)
- NYCMFF (1)
- Oil (2)
- Oncothyreon (4)
- ONTY (1)
- Opexa (1)
- options (8)
- Overstock (1)
- palifosfamide (1)
- Paramount Gold (10)
- Patrick Byrne (2)
- Peregrine Pharma (1)
- personal finance (3)
- Pharmathene (4)
- pilot (1)
- PIP (6)
- PML (2)
- Port24 (65)
- poverty (1)
- PPHM (1)
- presidential election (1)
- private accounts (1)
- Progenics (4)
- Propositions (2)
- Provenge (18)
- PZG (2)
- QQQQ (2)
- Rebalancing (2)
- refinance (1)
- Reg SHO (1)
- retirement (4)
- RFA (1)
- Rockwell Medical (3)
- Roth (1)
- Sangamo (19)
- Scottrade (2)
- Seattle Genetics (5)
- SEC (6)
- SGEN (2)
- SGMO (4)
- short selling (6)
- Social Security (1)
- state election (2)
- stock market (2)
- sufentanil (1)
- SuperGen (2)
- Syneron (1)
- Taser (3)
- tax (1)
- tax deferred (1)
- TED talks (1)
- Terry Pratchett (1)
- Thermodox (4)
- Todd Gurely (1)
- trp-p8 (1)
- Tysabri (6)
- unemployment (2)
- Uni-Pixel (1)
- UNXL (1)
- VHC (4)
- Vical (1)
- violence (1)
- VirnetX (5)
- volatility (2)
- Will Fuller (1)
- writing (1)
- Wyeth (2)
- Zecco (2)
- zinc fingers (1)
- ZIOP (4)
- Ziopharm Oncology (3)
No comments:
Post a Comment